Back to Authors

Moniz, Raymond J.

Mayo Clinic

Cue Biopharma Inc., Boston, MA, USA

Citations 1

636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
Margossian, Steven, Powderly, John , Gabrail, Nashat , Uboha, Nataliya V. , Ma, Wen , Jones, Jeremy , Alistar, Angela , Agensky, Laura, Goel, Apollina, Lynam, Reena, Moniz, Raymond J., Quayle, Steve, Rajan, Cynthia, Levisetti, Matteo, Jones, Jeremy C , Saenger, Yvonne M. , Selfridge, Jennifer Eva , Gong, Jun , Tine, Brian A. Van , Alese, Olatunji B. , Kim, Dae Won , Bekaii‐Saab, Tanios , Pienta, Kenneth J

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A667-A667

10.1136/jitc-2022-sitc2022.0636 Get It